Pharmacologically modified pluripotent stem cell-based cancer vaccines with anti-metastatic potential
Masae Heront-Kishi(Inserm), Frank Griscelli(Inserm)
Cited by 3
Related Papers
iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression
|International Journal of Molecular Sciences|2021|19